- Home
- JCTC vs BCTX Comparison
JCTC vs BCTX Comparison
Compare JCTC & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCTC
- BCTX
- Stock Information
- Founded
- JCTC 1953
- BCTX 2014
- Country
- JCTC United States
- BCTX Canada
- Employees
- JCTC N/A
- BCTX N/A
- Industry
- JCTC
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- JCTC
- BCTX Health Care
- Exchange
- JCTC NYSE
- BCTX Nasdaq
- Market Cap
- JCTC 14.7M
- BCTX 17.2M
- IPO Year
- JCTC 1996
- BCTX N/A
- Fundamental
- Price
- JCTC $4.20
- BCTX $0.60
- Analyst Decision
- JCTC
- BCTX Strong Buy
- Analyst Count
- JCTC 0
- BCTX 1
- Target Price
- JCTC N/A
- BCTX $15.00
- AVG Volume (30 Days)
- JCTC 7.8K
- BCTX 959.7K
- Earning Date
- JCTC 01-14-2025
- BCTX 12-12-2024
- Dividend Yield
- JCTC N/A
- BCTX N/A
- EPS Growth
- JCTC N/A
- BCTX N/A
- EPS
- JCTC 0.34
- BCTX N/A
- Revenue
- JCTC $48,553,695.00
- BCTX N/A
- Revenue This Year
- JCTC N/A
- BCTX N/A
- Revenue Next Year
- JCTC N/A
- BCTX N/A
- P/E Ratio
- JCTC $12.27
- BCTX N/A
- Revenue Growth
- JCTC N/A
- BCTX N/A
- 52 Week Low
- JCTC $3.86
- BCTX $0.46
- 52 Week High
- JCTC $6.35
- BCTX $5.97
- Technical
- Relative Strength Index (RSI)
- JCTC N/A
- BCTX 33.57
- Support Level
- JCTC N/A
- BCTX $0.57
- Resistance Level
- JCTC N/A
- BCTX $0.74
- Average True Range (ATR)
- JCTC 0.00
- BCTX 0.06
- MACD
- JCTC 0.00
- BCTX -0.02
- Stochastic Oscillator
- JCTC 0.00
- BCTX 7.58
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in United States and also has its presence in Canada, Latin America, Europe and Asia and other regions.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.